Zobrazeno 1 - 10
of 126
pro vyhledávání: '"Jong Hon Kang"'
Autor:
Kazunari Tanaka, Kunihiko Tsuji, Takeshi Matsui, Jong‐Hon Kang, Yasuo Sakurai, Yoshihisa Kodama, Ryosuke Minami, Kiichi Watanabe, Akio Katanuma
Publikováno v:
JGH Open, Vol 6, Iss 1, Pp 36-43 (2022)
Abstract Background and Aim With the control of viral hepatitis, alcoholic hepatocellular carcinoma (HCC) is becoming increasingly important in Japan. In alcoholic cirrhosis, the impact of portal hypertension is significant. Thus, it may be difficult
Externí odkaz:
https://doaj.org/article/b65a02ae64f54fae81ae47f86fec4b4c
Serum miR-192-5p levels predict the efficacy of pegylated interferon therapy for chronic hepatitis B
Autor:
Yoshihito Nagura, Kentaro Matsuura, Etsuko Iio, Koji Fujita, Takako Inoue, Akihiro Matsumoto, Eiji Tanaka, Shuhei Nishiguchi, Jong-Hon Kang, Takeshi Matsui, Masaru Enomoto, Hiroki Ikeda, Tsunamasa Watanabe, Chiaki Okuse, Masataka Tsuge, Masanori Atsukawa, Masakuni Tateyama, Hiromi Kataoka, Yasuhito Tanaka
Publikováno v:
PLoS ONE, Vol 17, Iss 2 (2022)
We examined the association between serum miRNA (-192-5p, -122-3p, -320a and -6126-5p) levels and the efficacy of pegylated interferon (Peg-IFN) monotherapy for chronic hepatitis B (CHB) patients. We enrolled 61 CHB patients treated with Peg-IFNα-2a
Externí odkaz:
https://doaj.org/article/5e3be7372cd6476098345d1fca77563d
Autor:
Hiromasa Ohira, Atsushi Takahashi, Mikio Zeniya, Masanori Abe, Teruko Arinaga‐Hino, Satoru Joshita, Akinobu Takaki, Nobuhiro Nakamoto, Jong‐Hon Kang, Yoshiyuki Suzuki, Tsuyosi Sogo, Ayano Inui, Kazuhiko Koike, Kenichi Harada, Yasunari Nakamoto, Yasuteru Kondo, Takuya Genda, Koichi Tsuneyama, Tsuyoshi Matsui, Atsushi Tanaka
Publikováno v:
Hepatology Research. 52:571-585
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee14f1dfc4dbc48d93d39ce63e3cb5ed
https://doi.org/10.1111/hepr.13776
https://doi.org/10.1111/hepr.13776
Autor:
Atsushi, Takahashi, Hiromasa, Ohira, Kazumichi, Abe, Mikio, Zeniya, Masanori, Abe, Teruko, Arinaga-Hino, Nobuhiro, Nakamoto, Akinobu, Takaki, Jong-Hon, Kang, Satoru, Joshita, Yoshiyuki, Suzuki, Kazuhiko, Koike, Ayano, Inui, Atsushi, Tanaka
Publikováno v:
Hepatology Research. 52:597-602
Some autoimmune hepatitis (AIH) patients experience relapse during their clinical course, and some risk factors for relapse have been identified previously using a relatively small sample size. The aim of the present study was to identify the risk fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62d4dec77aed1bd9ce8e352d8d6852ed
https://doi.org/10.1111/hepr.13766
https://doi.org/10.1111/hepr.13766
Autor:
Atsushi Takahashi, Kei Moriya, Hiromasa Ohira, Teruko Arinaga-Hino, Mikio Zeniya, Takuji Torimura, Masanori Abe, Akinobu Takaki, Jong-Hon Kang, Ayano Inui, Tomoo Fujisawa, Kaname Yoshizawa, Yoshiyuki Suzuki, Nobuhiro Nakamoto, Kazuhiko Koike, Hitoshi Yoshiji, Aya Goto, Atsushi Tanaka, Zobair M Younossi, Hajime Takikawa, Japan AIH Study Group
Publikováno v:
PLoS ONE, Vol 13, Iss 10, p e0204772 (2018)
AIM:Health-related quality of life is impaired in patients with autoimmune hepatitis, but the association between health-related quality of life and patients' backgrounds remains unknown. We assessed health-related quality of life in patients with au
Externí odkaz:
https://doaj.org/article/aafb37d725c6469dbcf6ade3cf12ad30
Autor:
Takeshi Matsui, Kazunari Tanaka, Ryosuke Minami, Kunihiko Tsuji, Jong-Hon Kang, Akio Katanuma, Akinori Yamazaki, Shinsuke Onishi
Publikováno v:
Kanzo. 63:463-464
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59edd2a86879dc32a3478723cef7efd3
https://doi.org/10.2957/kanzo.63.463
https://doi.org/10.2957/kanzo.63.463
Autor:
Satoru Joshita, Mie Inao, Kazuhito Kawata, Mie Arakawa, Toshihiko Arizumi, Tadashi Namisaki, Norifumi Kawada, Minami Yagi, Atsushi Tanaka, Akira Kaneko, Keisuke Kakisaka, Kentaro Kikuchi, Takeji Umemura, Akira Honda, Kosuke Matsumoto, Jong-Hon Kang, Mitsuhiko Aiso, Satoshi Mochida, Hideki Fujii, Yamato Tamura, Naoaki Hashimoto, Masashi Ninomiya, Atsumasa Komori, Jun Itakura, Tsutomu Masaki, Takako Nomura, Atsushi Takahashi, Masaaki Takamura, Hajime Takikawa, Ryo Miura, Hitoshi Yoshiji, Hiromasa Ohira, Masanori Abe, Yasuhiro Takikawa, Ken Sato, Yoshinari Asaoka
Publikováno v:
Liver International. 40:1926-1933
BACKGROUND/PURPOSE Although ursodeoxycholic acid (UDCA) is a first-line treatment for primary biliary cholangitis (PBC), 20%-30% of patients with PBC exhibit an incomplete response to UDCA. Recently, the UDCA Response Score was proposed for predictin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cc24245db4c586a96a5fd94b77c3e24
https://doi.org/10.1111/liv.14534
https://doi.org/10.1111/liv.14534
Serum miR-192-5p levels predict the efficacy of pegylated interferon therapy for chronic hepatitis B
Autor:
Hiroki Ikeda, Akihiro Matsumoto, Masataka Tsuge, Takako Inoue, Masakuni Tateyama, Kentaro Matsuura, Tsunamasa Watanabe, Masanori Atsukawa, Eiji Tanaka, Takeshi Matsui, Masaru Enomoto, Yasuhito Tanaka, Shuhei Nishiguchi, Jong-Hon Kang, Chiaki Okuse, Yoshihito Nagura, Hiromi Kataoka, Etsuko Iio, Koji Fujita
Publikováno v:
PLoS ONE, Vol 17, Iss 2 (2022)
PLoS ONE, Vol 17, Iss 2, p e0263844 (2022)
PLoS ONE, Vol 17, Iss 2, p e0263844 (2022)
We examined the association between serum miRNA (-192-5p, -122-3p, -320a and -6126-5p) levels and the efficacy of pegylated interferon (Peg-IFN) monotherapy for chronic hepatitis B (CHB) patients. We enrolled 61 CHB patients treated with Peg-IFNα-2a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbfbf1ef740e4636cf00bba61a3c5ceb
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843190/?tool=EBI
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843190/?tool=EBI
Autor:
Hitoshi Yoshiji, Jong-Hon Kang, Kentaro Kikuchi, Norifumi Kawada, Atsumasa Komori, Yasuhiro Takikawa, Satoru Joshita, Mie Inao, Mie Arakawa, Naoaki Hashimoto, Atsushi Takahashi, Hiromasa Ohira, Tadashi Namisaki, Kazuhito Kawata, Satoshi Iimuro, Akira Honda, Satoshi Yamagiwa, Hajime Takikawa, Masanori Abe, Keisuke Kakisaka, Akira Kaneko, Yasushi Matsuzaki, Ken Sato, Satoshi Mochida, Takeji Umemura, Tsutomu Masaki, Jun Itakura, Atsushi Tanaka, Hideki Fujii, Takako Nomura, Tetsuji Kaneko, Masashi Ninomiya
Publikováno v:
Hepatology. 70:2035-2046
In Japan, bezafibrate (BF) is a second-line agent for primary biliary cholangitis (PBC) that is refractory to ursodeoxycholic acid (UDCA) treatment. From a retrospective cohort (n = 873) from the Japan PBC Study Group, we enrolled 118 patients who ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d192d98b2d37401ca6e261866d43353
https://doi.org/10.1002/hep.30552
https://doi.org/10.1002/hep.30552
Autor:
Nao Nishida, Hiromi Sawai, Koichi Kashiwase, Mutsuhiko Minami, Masaya Sugiyama, Wai-Kay Seto, Man-Fung Yuen, Nawarat Posuwan, Yong Poovorawan, Sang Hoon Ahn, Kwang-Hyub Han, Kentaro Matsuura, Yasuhito Tanaka, Masayuki Kurosaki, Yasuhiro Asahina, Namiki Izumi, Jong-Hon Kang, Shuhei Hige, Tatsuya Ide, Kazuhide Yamamoto, Isao Sakaida, Yoshikazu Murawaki, Yoshito Itoh, Akihiro Tamori, Etsuro Orito, Yoichi Hiasa, Masao Honda, Shuichi Kaneko, Eiji Mita, Kazuyuki Suzuki, Keisuke Hino, Eiji Tanaka, Satoshi Mochida, Masaaki Watanabe, Yuichiro Eguchi, Naohiko Masaki, Kazumoto Murata, Masaaki Korenaga, Yoriko Mawatari, Jun Ohashi, Minae Kawashima, Katsushi Tokunaga, Masashi Mizokami
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e86449 (2014)
Previous studies have revealed the association between SNPs located on human leukocyte antigen (HLA) class II genes, including HLA-DP and HLA-DQ, and chronic hepatitis B virus (HBV) infection, mainly in Asian populations. HLA-DP alleles or haplotypes
Externí odkaz:
https://doaj.org/article/7d6ae97b78a745aa9f498075386541b3